Dopamine, serotonin and impulsivity

Neuroscience

Volumn 215, Issue , 2012, Pages 42-58

  Dalley, J W ^a,b   Roiser, J P ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

5 choice serial reaction time task; Delay discounting; Nucleus accumbens; Orbitofrontal cortex; Prefrontal cortex; Stop signal reaction time

Indexed keywords

DOPAMINE; SEROTONIN;

BEHAVIOR DISORDER; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; HUMAN; IMPULSIVENESS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; SEROTONINERGIC TRANSMISSION;

ANIMALS; BRAIN; DOPAMINE; HUMANS; IMPULSIVE BEHAVIOR; SEROTONIN;

EID: 84861805686     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.03.065     Document Type: Review

References (227)

1. Acheson A., de Wit H. Bupropion improves attention but does not affect impulsive behavior in healthy young adults. Exp Clin Psychopharmacol 2008, 16:113-123.
2. Adriani W., Canese R., Podo F., Laviola G. 1H MRS-detectable metabolic brain changes and reduced impulsive behavior in adult rats exposed to methylphenidate during adolescence. Neurotoxicol Teratol 2007, 29:116-125.
3. Ainslie G. Specious reward: a behavioral theory of impulsiveness and impulse control. Psychol Bull 1975, 82:463-496.
4. Anderson I.M., Richell R.A., Bradshaw C.M. The effect of acute tryptophan depletion on probabilistic choice. J Psychopharmacol 2003, 17:3-7.
5. Aron A.R., Dowson J.H., Sahakian B.J., Robbins T.W. Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2003, 54:1465-1468.
6. Asberg M., Nordstrom P., Traskman-Bendz L. Cerebrospinal fluid studies in suicide. An overview. Ann N Y Acad Sci 1986, 487:243-255.
7. Asberg M., Traskman L., Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?. Arch Gen Psychiatry 1976, 33:1193-1197.
8. Azmitia E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 1978, 179:641-667.
9. Baarendse P.J., Vanderschuren L.J. Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats. Psychopharmacology 2012, 219:313-326.
10. Bari A., Eagle D.M., Mar A.C., Robinson E.S., Robbins T.W. Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats. Psychopharmacology (Berl) 2009, 205:273-283.
11. Bari A., Mar A.C., Theobald D.E., Elands S.A., Oganya K.C., Eagle D.M., Robbins T.W. Prefrontal and monoaminergic contributions to stop-signal task performance in rats. J Neurosci 2011, 31:9254-9263.
12. Bechara A., Damasio A.R., Damasio H., Anderson S.W. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994, 50:7-15.
13. Bello E.P., Mateo Y., Gelman D.M., Noain D., Shin J.H., Low M.J., Alvarez V.A., Lovinger D.M., Rubinstein M. Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors. Nat Neurosci 2011, 14:1033-1038.
14. Besson M., Belin D., McNamara R., Theobald D.E., Castel A., Beckett V.L., Crittenden B.M., Newman A.H., Everitt B.J., Robbins T.W., Dalley J.W. Dissociable control of impulsivity in rats by dopamine d2/3 receptors in the core and shell subregions of the nucleus accumbens. Neuropsychopharmacology 2010, 35:560-569.
15. Bevilacqua L., Doly S., Kaprio J., Yuan Q., Tikkanen R., Paunio T., Zhou Z., Wedenoja J., Maroteaux L., Diaz S., Belmer A., Hodgkinson C.A., Dell'osso L., Suvisaari J., Coccaro E., Rose R.J., Peltonen L., Virkkunen M., Goldman D. A population-specific HTR2B stop codon predisposes to severe impulsivity. Nature 2010, 468:1061-1066.
16. Bizarro L., Patel S., Murtagh C., Stolerman I.P. Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate. Behav Pharmacol 2004, 15:195-206.
17. Bizot J., Le Bihan C., Puech A.J., Hamon M., Thiebot M. Serotonin and tolerance to delay of reward in rats. Psychopharmacology (Berl) 1999, 146:400-412.
18. Blokland A., Sik A., Lieben C. Evaluation of DOI, 8-OH-DPAT, eticlopride and amphetamine on impulsive responding in a reaction time task in rats. Behav Pharmacol 2005, 16:93-100.
19. Blondeau C., Dellu-Hagedorn F. Dimensional analysis of ADHD subtypes in rats. Biol Psychiatry 2007, 61:1340-1350.
20. Booij L., Swenne C.A., Brosschot J.F., Haffmans P.M., Thayer J.F., Van der Does A.J. Tryptophan depletion affects heart rate variability and impulsivity in remitted depressed patients with a history of suicidal ideation. Biol Psychiatry 2006, 60:507-514.
21. Booij L., Turecki G., Leyton M., Gravel P., Lopez De Lara C., Diksic M., Benkelfat C. Tryptophan hydroxylase(2) gene polymorphisms predict brain serotonin synthesis in the orbitofrontal cortex in humans. Mol Psychiatry 2011, 10.1038/mp.2011.79.
22. Bornovalova M.A., Lejuez C.W., Daughters S.B., Zachary Rosenthal M., Lynch T.R. Impulsivity as a common process across borderline personality and substance use disorders. Clin Psychol Rev 2005, 25:790-812.
23. Boy F., Evans C.J., Edden R.A., Lawrence A.D., Singh K.D., Husain M., Sumner P. Dorsolateral prefrontal gamma-aminobutyric acid in men predicts individual differences in rash impulsivity. Biol Psychiatry 2011, 70:866-872.
24. Bubar M.J., Stutz S.J., Cunningham K.A. 5-HT(2C) receptors localize to dopamine and GABA neurons in the rat mesoaccumbens pathway. PLoS ONE 2011, 6:e20508.
25. Buckholtz J.W., Treadway M.T., Cowan R.L., Woodward N.D., Li R., Ansari M.S., Baldwin R.M., Schwartzman A.N., Shelby E.S., Smith C.E., Kessler R.M., Zald D.H. Dopaminergic network differences in human impulsivity. Science 2010, 329:532.
26. Butler G.K., Montgomery A.M. Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use. Drug Alcohol Depend 2004, 76:55-62.
27. Butler T., Schofield P.W., Greenberg D., Allnutt S.H., Indig D., Carr V., D'Este C., Mitchell P.B., Knight L., Ellis A. Reducing impulsivity in repeat violent offenders: an open label trial of a selective serotonin reuptake inhibitor. Aust N Z J Psychiatry 2010, 44:1137-1143.
28. Cardinal R.N., Pennicott D.R., Sugathapala C.L., Robbins T.W., Everitt B.J. Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 2001, 292:2499-2501.
29. Cardinal R.N., Robbins T.W., Everitt B.J. The effects of d-amphetamine, chlordiazepoxide, alpha-flupenthixol and behavioural manipulations on choice of signalled and unsignalled delayed reinforcement in rats. Psychopharmacology (Berl) 2000, 152:362-375.
30. Carli M., Baviera M., Invernizzi R.W., Balducci C. Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats. Neuropsychopharmacology 2006, 31:757-767.
31. Castellanos F.X., Elia J., Kruesi M.J., Marsh W.L., Gulotta C.S., Potter W.Z., Ritchie G.F., Hamburger S.D., Rapoport J.L. Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder. Neuropsychopharmacology 1996, 14:125-137.
32. Chamberlain S.R., Muller U., Blackwell A.D., Clark L., Robbins T.W., Sahakian B.J. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 2006, 311:861-863.
33. Chamberlain S.R., Muller U., Deakin J.B., Corlett P.R., Dowson J., Cardinal R.N., Aitken M.R., Robbins T.W., Sahakian B.J. Lack of deleterious effects of buspirone on cognition in healthy male volunteers. J Psychopharmacol 2007, 21:210-215.
34. Chamberlain S.R., Sahakian B.J. The neuropsychiatry of impulsivity. Curr Opin Psychiatry 2007, 20:255-261.
35. Cherek D.R., Lane S.D. Effects of d,l-fenfluramine on aggressive and impulsive responding in adult males with a history of conduct disorder. Psychopharmacology (Berl) 1999, 146:473-481.
36. Cherek D.R., Lane S.D. Fenfluramine effects on impulsivity in a sample of adults with and without history of conduct disorder. Psychopharmacology (Berl) 2000, 152:149-156.
37. Cherek D.R., Lane S.D. Acute effects of D-fenfluramine on simultaneous measures of aggressive escape and impulsive responses of adult males with and without a history of conduct disorder. Psychopharmacology (Berl) 2001, 157:221-227.
38. Cherek D.R., Lane S.D., Pietras C.J., Steinberg J.L. Effects of chronic paroxetine administration on measures of aggressive and impulsive responses of adult males with a history of conduct disorder. Psychopharmacology (Berl) 2002, 159:266-274.
39. Clark L., Robbins T.W., Ersche K.D., Sahakian B.J. Reflection impulsivity in current and former substance users. Biol Psychiatry 2006, 60:515-522.
40. Clark L., Roiser J., Robbins T., Sahakian B. Disrupted 'reflection' impulsivity in cannabis users but not current or former ecstasy users. J Psychopharmacol 2009, 23:14-22.
41. Clark L., Roiser J.P., Cools R., Rubinsztein D.C., Sahakian B.J., Robbins T.W. Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology (Berl) 2005, 182:570-578.
42. Coccaro E.F., Siever L.J., Klar H.M., Maurer G., Cochrane K., Cooper T.B., Mohs R.C., Davis K.L. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 1989, 46:587-599.
43. Coccaro E.F., Silverman J.M., Klar H.M., Horvath T.B., Siever L.J. Familial correlates of reduced central serotonergic system function in patients with personality disorders. Arch Gen Psychiatry 1994, 51:318-324.
44. Cole B.J., Robbins T.W. Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: new evidence for central dopaminergic-noradrenergic interactions. Psychopharmacology (Berl) 1987, 91:458-466.
45. Cole B.J., Robbins T.W. Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav Brain Res 1989, 33:165-179.
46. Cools R., D'Esposito M. Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry 2011, 69:e113-e125.
47. Crean J., Richards J.B., de Wit H. Effect of tryptophan depletion on impulsive behavior in men with or without a family history of alcoholism. Behav Brain Res 2002, 136:349-357.
48. Crean J.P., de Wit H., Richards J.B. Reward discounting as a measure of impulsive behavior in a psychiatric outpatient population. Exp Clin Psychopharmacol 2000, 8:155-162.
49. Crockett M.J., Clark L., Robbins T.W. Reconciling the role of serotonin in behavioral inhibition and aversion: acute tryptophan depletion abolishes punishment-induced inhibition in humans. J Neurosci 2009, 29:11993-11999.
50. Dahlstroem A., Fuxe K. A method for the demonstration of monoamine-containing nerve fibres in the central nervous system. Acta Physiol Scand 1964, 60:293-294.
51. Dahlstroem A., Fuxe K., Olson L., Ungerstedt U. Ascending systems of catecholamine neurons from the lower brain stem. Acta Physiol Scand 1964, 62:485-486.
52. Dalley J.W., Everitt B.J., Robbins T.W. Impulsivity, compulsivity, and top-down cognitive control. Neuron 2011, 69:680-694.
53. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S., Theobald D.E., Laane K., Pena Y., Murphy E.R., Shah Y., Probst K., Abakumova I., Aigbirhio F.I., Richards H.K., Hong Y., Baron J.C., Everitt B.J., Robbins T.W. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
54. Dalley J.W., Theobald D.E., Pereira E.A., Li P.M., Robbins T.W. Specific abnormalities in serotonin release in the prefrontal cortex of isolation-reared rats measured during behavioural performance of a task assessing visuospatial attention and impulsivity. Psychopharmacology (Berl) 2002, 164:329-340.
55. de Wit H., Crean J., Richards J.B. Effects of d-amphetamine and ethanol on a measure of behavioral inhibition in humans. Behav Neurosci 2000, 114:830-837.
56. de Wit H., Enggasser J.L., Richards J.B. Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 2002, 27:813-825.
57. Devilbiss D.M., Berridge C.W. Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge. J Pharmacol Exp Ther 2006, 319:1327-1335.
58. DeVito E.E., Blackwell A.D., Clark L., Kent L., Dezsery A.M., Turner D.C., Aitken M.R., Sahakian B.J. Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD). Psychopharmacology (Berl) 2009, 202:531-539.
59. DeVito E.E., Blackwell A.D., Kent L., Ersche K.D., Clark L., Salmond C.H., Dezsery A.M., Sahakian B.J. The effects of methylphenidate on decision making in attention-deficit/hyperactivity disorder. Biol Psychiatry 2008, 64:636-639.
60. Dolan M., Deakin W.J., Roberts N., Anderson I. Serotonergic and cognitive impairment in impulsive aggressive personality disordered offenders: are there implications for treatment?. Psychol Med 2002, 32:105-117.
61. Dom G., De Wilde B., Hultstijn W., Sabbe B. Dimensions of impulsive behaviour in abstinent alcoholics. Pers Indiv Differ 2007, 42:465-476.
62. Dougherty D.M., Marsh D.M., Mathias C.W., Dawes M.A., Bradley D.M., Morgan C.J., Badawy A.A. The effects of alcohol on laboratory-measured impulsivity after L-tryptophan depletion or loading. Psychopharmacology (Berl) 2007, 193:137-150.
63. Dougherty D.M., Mathias C.W., Marsh D.M., Papageorgiou T.D., Swann A.C., Moeller F.G. Laboratory measured behavioral impulsivity relates to suicide attempt history. Suicide Life Threat Behav 2004, 34:374-385.
64. Durana J.H., Barnes P.A. A neurodevelopmental view of impulsivity and its relationship to the superfactors of personality. The impulsive client: theory, research and treatment 1993, American Psychological Association, Washington, DC. W.G. McCown (Ed.).
65. Eagle D.M., Bari A., Robbins T.W. The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berl) 2008, 199:439-456.
66. Eagle D.M., Lehmann O., Theobald D.E., Pena Y., Zakaria R., Ghosh R., Dalley J.W., Robbins T.W. Serotonin depletion impairs waiting but not stop-signal reaction time in rats: implications for theories of the role of 5-HT in behavioral inhibition. Neuropsychopharmacology 2009, 34:1311-1321.
67. Eagle D.M., Robbins T.W. Inhibitory control in rats performing a stop-signal reaction-time task: effects of lesions of the medial striatum and d-amphetamine. Behav Neurosci 2003, 117:1302-1317.
68. Eagle D.M., Tufft M.R., Goodchild H.L., Robbins T.W. Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology (Berl) 2007, 192:193-206.
69. Eagle D.M., Wong J.C., Allan M.E., Mar A.C., Theobald D.E., Robbins T.W. Contrasting roles for dopamine D1 and D2 receptor subtypes in the dorsomedial striatum but not the nucleus accumbens core during behavioral inhibition in the stop-signal task in rats. J Neurosci 2011, 31:7349-7356.
70. Ersche K.D., Turton A.J., Pradhan S., Bullmore E.T., Robbins T.W. Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biol Psychiatry 2010, 68:770-773.
71. Evenden J. Impulsivity: a discussion of clinical and experimental findings. J Psychopharmacol 1999, 13:180-192.
72. Evenden J.L. Varieties of impulsivity. Psychopharmacology (Berl) 1999, 146:348-361.
73. Evenden J.L., Ryan C.N. The pharmacology of impulsive behaviour in rats VI: the effects of ethanol and selective serotonergic drugs on response choice with varying delays of reinforcement. Psychopharmacology (Berl) 1999, 146:413-421.
74. Eysenck H.J., Eysenck S.B.G. Adult impulsiveness, venturesomeness and empathy scale 1991, Hodder Soughton, London.
75. Feola T.W., de Wit H., Richards J.B. Effects of d-amphetamine and alcohol on a measure of behavioral inhibition in rats. Behav Neurosci 2000, 114:838-848.
76. Fink K.B., Gothert M. 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev 2007, 59:360-417.
77. Fletcher P.J., Tampakeras M., Sinyard J., Higgins G.A. Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test. Psychopharmacology (Berl) 2007, 195:223-234.
78. Floresco S.B., Tse M.T., Ghods-Sharifi S. Dopaminergic and glutamatergic regulation of effort- and delay-based decision making. Neuropsychopharmacology 2008, 33:1966-1979.
79. Franken I.H., van Strien J.W., Nijs I., Muris P. Impulsivity is associated with behavioral decision-making deficits. Psychiatry Res 2008, 158:155-163.
80. Frankle W.G., Lombardo I., New A.S., Goodman M., Talbot P.S., Huang Y., Hwang D.R., Slifstein M., Curry S., Abi-Dargham A., Laruelle M., Siever L.J. Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry 2005, 162:915-923.
81. Gerasimov M.R., Franceschi M., Volkow N.D., Rice O., Schiffer W.K., Dewey S.L. Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor. Synapse 2000, 38:432-437.
82. Green A.R., Mechan A.O., Elliott J.M., O'Shea E., Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, " ecstasy" ). Pharmacol Rev 2003, 55:463-508.
83. Hadamitzky M., Feja M., Becker T., Koch M. Effects of acute systemic administration of serotonin2A/C receptor ligands in a delay-based decision-making task in rats. Behav Pharmacol 2009, 20:415-423.
84. Halpern J.H., Pope H.G., Sherwood A.R., Barry S., Hudson J.I., Yurgelun-Todd D. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend 2004, 75:135-147.
85. Halpern J.H., Sherwood A.R., Hudson J.I., Gruber S., Kozin D., Pope H.G. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs. Addiction 2011, 106:777-786.
86. Hamidovic A., Dlugos A., Skol A., Palmer A.A., de Wit H. Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. Exp Clin Psychopharmacol 2009, 17:374-383.
87. Hamidovic A., Kang U.J., de Wit H. Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers. J Clin Psychopharmacol 2008, 28:45-51.
88. Hanna G.L., Ornitz E.M., Hariharan M. Urinary catecholamine excretion and behavioral differences in ADHD and normal boys. J Child Adolesc Psychopharmacol 1996, 6:63-73.
89. Harmer C.J., McTavish S.F., Clark L., Goodwin G.M., Cowen P.J. Tyrosine depletion attenuates dopamine function in healthy volunteers. Psychopharmacology (Berl) 2001, 154:105-111.
90. Harrison A.A., Everitt B.J., Robbins T.W. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology (Berl) 1997, 133:329-342.
91. Harrison A.A., Everitt B.J., Robbins T.W. Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go/no-go conditional visual discrimination. Behav Brain Res 1999, 100:99-112.
92. Hayes D.J., Greenshaw A.J. 5-HT receptors and reward-related behaviour: a review. Neurosci Biobehav Rev 2011, 35:1419-1449.
93. Helms C.M., Reeves J.M., Mitchell S.H. Impact of strain and D-amphetamine on impulsivity (delay discounting) in inbred mice. Psychopharmacology 2006, 188:144-151.
94. Hetrick S., Merry S., McKenzie J., Sindahl P., Proctor M. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Cochrane Database Syst Rev 2007, CD004851.
95. Hoffman W.F., Moore M., Templin R., McFarland B., Hitzemann R.J., Mitchell S.H. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology (Berl) 2006, 188:162-170.
96. Hollander E., Cohen L.J. Impulsivity and compulsivity 1996, American Psychiatric Press Inc., Washington, DC.
97. Horesh N. Self-report vs. computerized measures of impulsivity as a correlate of suicidal behavior. Crisis 2001, 22:27-31.
98. Housden C.R., O'Sullivan S.S., Joyce E.M., Lees A.J., Roiser J.P. Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviors. Neuropsychopharmacology 2010, 35:2155-2164.
99. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., Xu K., Arnold P.D., Richter M.A., Kennedy J.L., Murphy D.L., Goldman D. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 2006, 78:815-826.
100. Isles A.R., Humby T., Wilkinson L.S. Measuring impulsivity in mice using a novel operant delayed reinforcement task: effects of behavioural manipulations and d-amphetamine. Psychopharmacology (Berl) 2003, 170:376-382.
101. Kagan J., Rosman B.L., Day D., Albert J., Phillips W. Information processing in the child: significance of analytic and reflective attitudes. Psychol Monogr 1964, 78:1. (Whole No. 578).
102. Kelly T.H., Robbins G., Martin C.A., Fillmore M.T., Lane S.D., Harrington N.G., Rush C.R. Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status. Psychopharmacology (Berl) 2006, 189:17-25.
103. Kirby K.N., Finch J.C. The hierarchical structure of self-reported impulsivity. Pers Indiv Differ 2010, 48:704-713.
104. Klonsky E.D., May A. Rethinking impulsivity in suicide. Suicide Life Threat Behav 2010, 40:612-619.
105. Kollins S.H., March J.S. Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder. Biol Psychiatry 2007, 62:951-953.
106. Koskinen T., Ruotsalainen S., Sirvio J. The 5-HT(2) receptor activation enhances impulsive responding without increasing motor activity in rats. Pharmacol Biochem Behav 2000, 66:729-738.
107. Kuczenski R., Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 1997, 68:2032-2037.
108. Lage G.M., Malloy-Diniz L.F., Matos L.O., Bastos M.A., Abrantes S.S., Correa H. Impulsivity and the 5-HTTLPR polymorphism in a non-clinical sample. PLoS ONE 2011, 6:e16927.
109. Lane S.D., Cherek D.R., Rhodes H.M., Pietras C.J., Tcheremissine O.V. Relationships among laboratory and psychometric measures of impulsivity: implications in substance abuse and dependence. Addict Dis Treat 2003, 2:33-40.
110. Lee B., London E.D., Poldrack R.A., Farahi J., Nacca A., Monterosso J.R., Mumford J.A., Bokarius A.V., Dahlbom M., Mukherjee J., Bilder R.M., Brody A.L., Mandelkern M.A. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci 2009, 29:14734-14740.
111. LeMarquand D.G., Benkelfat C., Pihl R.O., Palmour R.M., Young S.N. Behavioral disinhibition induced by tryptophan depletion in nonalcoholic young men with multigenerational family histories of paternal alcoholism. Am J Psychiatry 1999, 156:1771-1779.
112. LeMarquand D.G., Pihl R.O., Young S.N., Tremblay R.E., Seguin J.R., Palmour R.M., Benkelfat C. Tryptophan depletion, executive functions, and disinhibition in aggressive, adolescent males. Neuropsychopharmacology 1998, 19:333-341.
113. Leyton M., Dagher A., Boileau I., Casey K., Baker G.B., Diksic M., Gunn R., Young S.N., Benkelfat C. Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacology 2004, 29:427-432.
114. Lindstrom M.B., Ryding E., Bosson P., Ahnlide J.A., Rosen I., Traskman-Bendz L. Impulsivity related to brain serotonin transporter binding capacity in suicide attempters. Eur Neuropsychopharmacol 2004, 14:295-300.
115. Linnoila M., Virkkunen M., Scheinin M., Nuutila A., Rimon R., Goodwin F.K. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci 1983, 33:2609-2614.
116. Logan G., Schachar R., Tannock R. Impulsivity and inhibitory control. Psychol Sci 1997, 8:60-64.
117. Logan G.D. On the ability to inhibit thought and action. Inhibitory processes in attention memory and language 1994, 189-239. Academic Press, San Diego. D. Dagenback, T.H. Carr (Eds.).
118. Loos M., Pattij T., Janssen M.C., Counotte D.S., Schoffelmeer A.N., Smit A.B., Spijker S., van Gaalen M.M. Dopamine receptor D1/D5 gene expression in the medial prefrontal cortex predicts impulsive choice in rats. Cereb Cortex 2010, 20:1064-1070.
119. Love T.M., Stohler C.S., Zubieta J.K. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. Arch Gen Psychiatry 2009, 66:1124-1134.
120. Lythe K.E., Anderson I.M., Deakin J.F., Elliott R., Strickland P.L. Lack of behavioural effects after acute tyrosine depletion in healthy volunteers. J Psychopharmacol 2005, 19:5-11.
121. Malloy-Diniz L.F., Neves F.S., de Moraes P.H., De Marco L.A., Romano-Silva M.A., Krebs M.O., Correa H. The 5-HTTLPR polymorphism, impulsivity and suicide behavior in euthymic bipolar patients. J Affect Disord 2011, 133:221-226.
122. Mann J.J., Brent D.A., Arango V. The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology 2001, 24:467-477.
123. Mann J.J., McBride P.A., Brown R.P., Linnoila M., Leon A.C., DeMeo M., Mieczkowski T., Myers J.E., Stanley M. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch Gen Psychiatry 1992, 49:442-446.
124. Manuck S.B., Flory J.D., McCaffery J.M., Matthews K.A., Mann J.J., Muldoon M.F. Aggression, impulsivity, and central nervous system serotonergic responsivity in a nonpatient sample. Neuropsychopharmacology 1998, 19:287-299.
125. Masaki D., Yokoyama C., Kinoshita S., Tsuchida H., Nakatomi Y., Yoshimoto K., Fukui K. Relationship between limbic and cortical 5-HT neurotransmission and acquisition and reversal learning in a go/no-go task in rats. Psychopharmacology (Berl) 2006, 189:249-258.
126. Mazur J.E., Coe D. Tests of transitivity in choices between fixed and variable reinforcer delays. J Exp Anal Behav 1987, 47:287-297.
127. McLean A., Rubinsztein J.S., Robbins T.W., Sahakian B.J. The effects of tyrosine depletion in normal healthy volunteers: implications for unipolar depression. Psychopharmacology (Berl) 2004, 171:286-297.
128. McMahon L.R., Filip M., Cunningham K.A. Differential regulation of the mesoaccumbens circuit by serotonin 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. J Neurosci 2001, 21:7781-7787.
129. Meda S.A., Stevens M.C., Potenza M.N., Pittman B., Gueorguieva R., Andrews M.M., Thomas A.D., Muska C., Hylton J.L., Pearlson G.D. Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis. Behav Pharmacol 2009, 20:390-399.
130. Miyazaki K., Miyazaki K.W., Doya K. Activation of dorsal raphe serotonin neurons underlies waiting for delayed rewards. J Neurosci 2011, 31:469-479.
131. Mobini S., Chiang T.J., Al-Ruwaitea A.S., Ho M.Y., Bradshaw C.M., Szabadi E. Effect of central 5-hydroxytryptamine depletion on inter-temporal choice: a quantitative analysis. Psychopharmacology (Berl) 2000, 149:313-318.
132. Mobini S., Chiang T.J., Ho M.Y., Bradshaw C.M., Szabadi E. Effects of central 5-hydroxytryptamine depletion on sensitivity to delayed and probabilistic reinforcement. Psychopharmacology (Berl) 2000, 152:390-397.
133. Moeller F.G., Barratt E.S., Dougherty D.M., Schmitz J.M., Swann A.C. Psychiatric aspects of impulsivity. Am J Psychiatry 2001, 158:1783-1793.
134. Moeller F.G., Dougherty D.M., Barratt E.S., Oderinde V., Mathias C.W., Harper R.A., Swann A.C. Increased impulsivity in cocaine dependent subjects independent of antisocial personality disorder and aggression. Drug Alcohol Depend 2002, 68:105-111.
135. Monterosso J.R., Aron A.R., Cordova X., Xu J., London E.D. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend 2005, 79:273-277.
136. Montgomery A.J., McTavish S.F., Cowen P.J., Grasby P.M. Reduction of brain dopamine concentration with dietary tyrosine plus phenylalanine depletion: an [(11)C]raclopride PET study. Am J Psychiatry 2003, 160:1887-1889.
137. Morgan M.J. Recreational use of " ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 1998, 19:252-264.
138. Morgan M.J., Impallomeni L.C., Pirona A., Rogers R.D. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naive controls. Neuropsychopharmacology 2006, 31:1562-1573.
139. Morgan M.J., McFie L., Fleetwood H., Robinson J.A. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?. Psychopharmacology (Berl) 2002, 159:294-303.
140. O'Sullivan S.S., Evans A.H., Lees A.J. Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management. CNS Drugs 2009, 23:157-170.
141. Oades R.D. Dopamine may be 'hyper' with respect to noradrenaline metabolism, but 'hypo' with respect to serotonin metabolism in children with attention-deficit hyperactivity disorder. Behav Brain Res 2002, 130:97-102.
142. Oades R.D. Role of the serotonin system in ADHD: treatment implications. Expert Rev Neurother 2007, 7:1357-1374.
143. Oades R.D., Lasky-Su J., Christiansen H., Faraone S.V., Sonuga-Barke E.J., Banaschewski T., Chen W., Anney R.J., Buitelaar J.K., Ebstein R.P., Franke B., Gill M., Miranda A., Roeyers H., Rothenberger A., Sergeant J.A., Steinhausen H.C., Taylor E.A., Thompson M., Asherson P. The influence of serotonin- and other genes on impulsive behavioral aggression and cognitive impulsivity in children with attention-deficit/hyperactivity disorder (ADHD): findings from a family-based association test (FBAT) analysis. Behav Brain Funct 2008, 4:48.
144. Obeso I., Wilkinson L., Jahanshahi M. Levodopa medication does not influence motor inhibition or conflict resolution in a conditional stop-signal task in Parkinson's disease. Exp Brain Res 2011, 213:435-445.
145. Olmstead M.C., Ouagazzal A.M., Kieffer B.L. Mu and delta opioid receptors oppositely regulate motor impulsivity in the signaled nose poke task. PLoS ONE 2009, 4:e4410.
146. Oswald L.M., Wong D.F., Zhou Y., Kumar A., Brasic J., Alexander M., Ye W., Kuwabara H., Hilton J., Wand G.S. Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release. Neuroimage 2007, 36:153-166.
147. Overtoom C.C., Verbaten M.N., Kemner C., Kenemans J.L., van Engeland H., Buitelaar J.K., van der Molen M.W., van der Gugten J., Westenberg H., Maes R.A., Koelega H.S. Effects of methylphenidate, desipramine, and L-dopa on attention and inhibition in children with Attention Deficit Hyperactivity Disorder. Behav Brain Res 2003, 145:7-15.
148. Pattij T., Janssen M.C., Vanderschuren L.J., Schoffelmeer A.N., van Gaalen M.M. Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control. Psychopharmacology (Berl) 2007, 191:587-598.
149. Pattij T., Schetters D., Schoffelmeer A.N., van Gaalen M.M. On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists. Psychopharmacology (Berl) 2012, 219:327-340.
150. Patton J.H., Stanford M.S., Barratt E.S. Factor structure of the Barratt impulsiveness scale. J Clin Psychol 1995, 51:768-774.
151. Pezze M.A., Dalley J.W., Robbins T.W. Remediation of attentional dysfunction in rats with lesions of the medial prefrontal cortex by intra-accumbens administration of the dopamine D(2/3) receptor antagonist sulpiride. Psychopharmacology (Berl) 2009, 202:307-313.
152. Pine A., Shiner T., Seymour B., Dolan R.J. Dopamine, time, and impulsivity in humans. J Neurosci 2010, 30:8888-8896.
153. Pothuizen H.H., Jongen-Relo A.L., Feldon J., Yee B.K. Double dissociation of the effects of selective nucleus accumbens core and shell lesions on impulsive-choice behaviour and salience learning in rats. Eur J Neurosci 2005, 22:2605-2616.
154. Puumala T., Ruotsalainen S., Jakala P., Koivisto E., Riekkinen P., Sirvio J. Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder. Neurobiol Learn Mem 1996, 66:198-211.
155. Puumala T., Sirvio J. Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task. Neuroscience 1998, 83:489-499.
156. Quednow B.B., Kuhn K.U., Hoppe C., Westheide J., Maier W., Daum I., Wagner M. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA (" Ecstasy" ). Psychopharmacology (Berl) 2007, 189:517-530.
157. Reist C., Mazzanti C., Vu R., Tran D., Goldman D. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. Am J Med Genet 2001, 105:363-368.
158. Reynolds B., Ortengren A., Richards J.B., de Wit H. Dimensions of impulsive behavior: personality and behavioral measures. Pers Indiv Differ 2006, 20:305-315.
159. Richards J.B., Zhang L., Mitchell S.H., de Wit H. Delay or probability discounting in a model of impulsive behavior: effect of alcohol. J Exp Anal Behav 1999, 71:121-143.
160. Rinne T., van den Brink W., Wouters L., van Dyck R. SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry 2002, 159:2048-2054.
161. Robbins T.W. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 2002, 163:362-380.
162. Robbins T.W., Sahakian B.J. " Paradoxical" effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology. Neuropharmacology 1979, 18:931-950.
163. Robinson E.S., Dalley J.W., Theobald D.E., Glennon J.C., Pezze M.A., Murphy E.R., Robbins T.W. Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task. Neuropsychopharmacology 2008, 33:2398-2406.
164. Robinson E.S., Eagle D.M., Economidou D., Theobald D.E., Mar A.C., Murphy E.R., Robbins T.W., Dalley J.W. Behavioural characterisation of high impulsivity on the 5-choice serial reaction time task: specific deficits in 'waiting' versus 'stopping'. Behav Brain Res 2009, 196:310-316.
165. Robinson E.S., Eagle D.M., Mar A.C., Bari A., Banerjee G., Jiang X., Dalley J.W., Robbins T.W. Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 2008, 33:1028-1037.
166. Robinson O.J., Cools R., Sahakian B.J. Tryptophan depletion disinhibits punishment but not reward prediction: implications for resilience. Psychopharmacology (Berl) 2012, 219:599-605.
167. Rogers R.D., Everitt B.J., Baldacchino A., Blackshaw A.J., Swainson R., Wynne K., Baker N.B., Hunter J., Carthy T., Booker E., London M., Deakin J.F., Sahakian B.J., Robbins T.W. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 1999, 20:322-339.
168. Roiser J.P., McLean A., Ogilvie A.D., Blackwell A.D., Bamber D.J., Goodyer I., Jones P.B., Sahakian B.J. The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression. Neuropsychopharmacology 2005, 30:775-785.
169. Roiser J.P., Rogers R.D., Sahakian B.J. Neuropsychological function in ecstasy users: a study controlling for polydrug use. Psychopharmacology (Berl) 2007, 189:505-516.
170. Rosa-Neto P., Lou H.C., Cumming P., Pryds O., Karrebaek H., Lunding J., Gjedde A. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage 2005, 25:868-876.
171. Rosa Neto P., Lou H., Cumming P., Pryds O., Gjedde A. Methylphenidate-evoked potentiation of extracellular dopamine in the brain of adolescents with premature birth: correlation with attentional deficit. Ann N Y Acad Sci 2002, 965:434-439.
172. Rossi M., Gerschcovich E.R., de Achaval D., Perez-Lloret S., Cerquetti D., Cammarota A., Ines Nouzeilles M., Fahrer R., Merello M., Leiguarda R. Decision-making in Parkinson's disease patients with and without pathological gambling. Eur J Neurol 2010, 17:97-102.
173. Ryding E., Ahnlide J.A., Lindstrom M., Rosen I., Traskman-Bendz L. Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy. Psychiatry Res 2006, 148:195-203.
174. Sakai J.T., Young S.E., Stallings M.C., Timberlake D., Smolen A., Stetler G.L., Crowley T.J. Case-control and within-family tests for an association between conduct disorder and 5HTTLPR. Am J Med Genet B Neuropsychiatr Genet 2006, 141B:825-832.
175. Schachar R., Logan G.D., Robaey P., Chen S., Ickowicz A., Barr C. Restraint and cancellation: multiple inhibition deficits in attention deficit hyperactivity disorder. J Abnorm Child Psychol 2007, 35:229-238.
176. Scheres A., Oosterlaan J., Swanson J., Morein-Zamir S., Meiran N., Schut H., Vlasveld L., Sergeant J.A. The effect of methylphenidate on three forms of response inhibition in boys with AD/HD. J Abnorm Child Psychol 2003, 31:105-120.
177. Schilt T., Koeter M.W., Smal J.P., Gouwetor M.N., van den Brink W., Schmand B. Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users. Psychopharmacology (Berl) 2010, 207:583-591.
178. Schmidt C.A., Fallon A.E., Coccaro E.F. Assessment of behavioral and cognitive impulsivity: development and validation of the Lifetime History of Impulsive Behaviors Interview. Psychiatry Res 2004, 126:107-121.
179. Schweighofer N., Bertin M., Shishida K., Okamoto Y., Tanaka S.C., Yamawaki S., Doya K. Low-serotonin levels increase delayed reward discounting in humans. J Neurosci 2008, 28:4528-4532.
180. Shaywitz B.A., Cohen D.J., Bowers M.B. CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine. A preliminary report. J Pediatr 1977, 90:67-71.
181. Silva H., Iturra P., Solari A., Villarroel J., Jerez S., Jimenez M., Galleguillos F., Bustamante M.L. Fluoxetine response in impulsive-aggressive behavior and serotonin transporter polymorphism in personality disorder. Psychiatr Genet 2010, 20:25-30.
182. Slezak J.M., Anderson K.G. Effects of variable training, signaled and unsignaled delays, and d-amphetamine on delay-discounting functions. Behav Pharmacol 2009, 20:424-436.
183. Solanto M.V., Abikoff H., Sonuga-Barke E., Schachar R., Logan G.D., Wigal T., Hechtman L., Hinshaw S., Turkel E. The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multimodal treatment study of AD/HD. J Abnorm Child Psychol 2001, 29:215-228.
184. Soloff P. Special feature: psychobiologic perspectives on treatment of personality disorders. J Pers Disord 1997, 11:336-344.
185. Soloff P.H., Kelly T.M., Strotmeyer S.J., Malone K.M., Mann J.J. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder. Psychiatry Res 2003, 119:11-24.
186. Soubrié P. Reconciling the role of central serotonin neurons in human and animal behavior. Behav Brain Sci 1986, 9:319-335.
187. St Onge J.R., Floresco S.B. Dopaminergic modulation of risk-based decision making. Neuropsychopharmacology 2009, 34:681-697.
188. St Onge J.R., Floresco S.B. Prefrontal cortical contribution to risk-based decision making. Cereb Cortex 2010, 20:1816-1828.
189. Stanis J.J., Marquez Avila H., White M.D., Gulley J.M. Dissociation between long-lasting behavioral sensitization to amphetamine and impulsive choice in rats performing a delay-discounting task. Psychopharmacology 2008, 199:539-548.
190. Stanislaw H., Todorov N. Calculation of signal detection theory measures. Behav Res Methods Instrum Comput 1999, 31:137-149.
191. Steeves T.D., Miyasaki J., Zurowski M., Lang A.E., Pellecchia G., Van Eimeren T., Rusjan P., Houle S., Strafella A.P. Increased striatal dopamine release in parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 2009, 132:1376-1385.
192. Stoltenberg S.F., Glass J.M., Chermack S.T., Flynn H.A., Li S., Weston M.E., Burmeister M. Possible association between response inhibition and a variant in the brain-expressed tryptophan hydroxylase-2 gene. Psychiatr Genet 2006, 16:35-38.
193. Swann A.C. Impulsivity in mania. Curr Psychiatry Rep 2009, 11:481-487.
194. Swann A.C., Bjork J.M., Moeller F.G., Dougherty D.M. Two models of impulsivity: relationship to personality traits and psychopathology. Biol Psychiatry 2002, 51:988-994.
195. Swann A.C., Dougherty D.M., Pazzaglia P.J., Pham M., Steinberg J.L., Moeller F.G. Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am J Psychiatry 2005, 162:1680-1687.
196. Swanson J.M., Volkow N.D. Psychopharmacology: concepts and opinions about the use of stimulant medications. J Child Psychol Psychiatry 2009, 50:180-193.
197. Talbot P.S., Watson D.R., Barrett S.L., Cooper S.J. Rapid tryptophan depletion improves decision-making cognition in healthy humans without affecting reversal learning or set shifting. Neuropsychopharmacology 2006, 31:1519-1525.
198. Talpos J.C., Wilkinson L.S., Robbins T.W. A comparison of multiple 5-HT receptors in two tasks measuring impulsivity. J Psychopharmacol 2006, 20:47-58.
199. Tannock R., Schachar R.J., Carr R.P., Chajczyk D., Logan G.D. Effects of methylphenidate on inhibitory control in hyperactive children. J Abnorm Child Psychol 1989, 17:473-491.
200. Turner D.C., Blackwell A.D., Dowson J.H., McLean A., Sahakian B.J. Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) 2005, 178:286-295.
201. Tye N.C., Everitt B.J., Iversen S.D. 5-Hydroxytryptamine and punishment. Nature 1977, 268:741-743.
202. Van den Eynde F., Senturk V., Naudts K., Vogels C., Bernagie K., Thas O., van Heeringen C., Audenaert K. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder. J Clin Psychopharmacol 2008, 28:147-155.
203. van Gaalen M.M., van Koten R., Schoffelmeer A.N., Vanderschuren L.J. Critical involvement of dopaminergic neurotransmission in impulsive decision making. Biol Psychiatry 2006, 60:66-73.
204. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Ding Y.S., Sedler M., Logan J., Franceschi D., Gatley J., Hitzemann R., Gifford A., Wong C., Pappas N. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001, 158:2015-2021.
205. Volkow N.D., Wang G.J., Kollins S.H., Wigal T.L., Newcorn J.H., Telang F., Fowler J.S., Zhu W., Logan J., Ma Y., Pradhan K., Wong C., Swanson J.M. Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA 2009, 302:1084-1091.
206. Volkow N.D., Wang G.J., Newcorn J., Telang F., Solanto M.V., Fowler J.S., Logan J., Ma Y., Schulz K., Pradhan K., Wong C., Swanson J.M. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2007, 64:932-940.
207. Voon V., Pessiglione M., Brezing C., Gallea C., Fernandez H.H., Dolan R.J., Hallett M. Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 2010, 65:135-142.
208. Voon V., Reynolds B., Brezing C., Gallea C., Skaljic M., Ekanayake V., Fernandez H., Potenza M.N., Dolan R.J., Hallett M. Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl) 2010, 207:645-659.
209. Wade T.R., de Wit H., Richards J.B. Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats. Psychopharmacology (Berl) 2000, 150:90-101.
210. Walderhaug E., Herman A.I., Magnusson A., Morgan M.J., Landro N.I. The short (S) allele of the serotonin transporter polymorphism and acute tryptophan depletion both increase impulsivity in men. Neurosci Lett 2010, 473:208-211.
211. Walderhaug E., Lunde H., Nordvik J.E., Landro N.I., Refsum H., Magnusson A. Lowering of serotonin by rapid tryptophan depletion increases impulsiveness in normal individuals. Psychopharmacology (Berl) 2002, 164:385-391.
212. Walderhaug E., Magnusson A., Neumeister A., Lappalainen J., Lunde H., Refsum H., Landro N.I. Interactive effects of sex and 5-HTTLPR on mood and impulsivity during tryptophan depletion in healthy people. Biol Psychiatry 2007, 62:593-599.
213. Whiteside S.P., Lynam D.R. The Five Factor Model and impulsivity: using a structural model of personality to understand impulsivity. Pers Indiv Differ 2001, 30:669-689.
214. Williams W.A., Shoaf S.E., Hommer D., Rawlings R., Linnoila M. Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. J Neurochem 1999, 72:1641-1647.
215. Winstanley C.A., Cocker P.J., Rogers R.D. Dopamine modulates reward expectancy during performance of a slot machine task in rats: evidence for a 'near-miss' effect. Neuropsychopharmacology 2011, 36:913-925.
216. Winstanley C.A., Dalley J.W., Theobald D.E., Robbins T.W. Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats. Psychopharmacology (Berl) 2003, 170:320-331.
217. Winstanley C.A., Dalley J.W., Theobald D.E., Robbins T.W. Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology 2004, 29:1331-1343.
218. Winstanley C.A., Eagle D.M., Robbins T.W. Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev 2006, 26:379-395.
219. Winstanley C.A., Theobald D.E., Dalley J.W., Cardinal R.N., Robbins T.W. Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb Cortex 2006, 16:106-114.
220. Winstanley C.A., Theobald D.E., Dalley J.W., Robbins T.W. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Neuropsychopharmacology 2005, 30:669-682.
221. Wogar M.A., Bradshaw C.M., Szabadi E. Effect of lesions of the ascending 5-hydroxytryptaminergic pathways on choice between delayed reinforcers. Psychopharmacology (Berl) 1993, 111:239-243.
222. Wolff M.C., Leander J.D. Selective serotonin reuptake inhibitors decrease impulsive behavior as measured by an adjusting delay procedure in the pigeon. Neuropsychopharmacology 2002, 27:421-429.
223. Wooters T.E., Bardo M.T. Methylphenidate and fluphenazine, but not amphetamine, differentially affect impulsive choice in Spontaneously Hypertensive, Wistar-Kyoto and Sprague-Dawley rats. Brain Res 2011, 1396:45-53.
224. Zeeb F.D., Floresco S.B., Winstanley C.A. Contributions of the orbitofrontal cortex to impulsive choice: interactions with basal levels of impulsivity, dopamine signalling, and reward-related cues. Psychopharmacology (Berl) 2010, 211:87-98.
225. Zeeb F.D., Robbins T.W., Winstanley C.A. Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. Neuropsychopharmacology 2009, 34:2329-2343.
226. Zermatten A., Van der Linden M., d'Acremont M., Jermann F., Bechara A. Impulsivity and decision making. J Nerv Ment Dis 2005, 193:647-650.
227. Zhang Y., Bertolino A., Fazio L., Blasi G., Rampino A., Romano R., Lee M.L., Xiao T., Papp A., Wang D., Sadee W. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci USA 2007, 104:20552-20557.